Literature DB >> 12724633

Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Douglas G Farmer1, Dean M Anselmo, R Mark Ghobrial, Hasan Yersiz, Suzanne V McDiarmid, Carlos Cao, Michael Weaver, Jesus Figueroa, Khurram Khan, Jorge Vargas, Sammy Saab, Steven Han, Francisco Durazo, Leonard Goldstein, Curtis Holt, Ronald W Busuttil.   

Abstract

OBJECTIVE: To analyze outcomes after liver transplantation (LT) in patients with fulminant hepatic failure (FHF) with emphasis on pretransplant variables that can potentially help predict posttransplant outcome. SUMMARY BACKGROUND DATA: FHF is a formidable clinical problem associated with a high mortality rate. While LT is the treatment of choice for irreversible FHF, few investigations have examined pretransplant variables that can potentially predict outcome after LT.
METHODS: A retrospective review was undertaken of all patients undergoing LT for FHF at a single transplant center. The median follow-up was 41 months. Thirty-five variables were analyzed by univariate and multivariate analysis to determine their impact on patient and graft survival.
RESULTS: Two hundred four patients (60% female, median age 20.2 years) required urgent LT for FHF. Before LT, the majority of patients were comatose (76%), on hemodialysis (16%), and ICU-bound. The 1- and 5-year survival rates were 73% and 67% (patient) and 63% and 57% (graft). The primary cause of patient death was sepsis, and the primary cause of graft failure was primary graft nonfunction. Univariate analysis of pre-LT variables revealed that 19 variables predicted survival. From these results, multivariate analysis determined that the serum creatinine was the single most important prognosticator of patient survival.
CONCLUSIONS: This study, representing one of the largest published series on LT for FHF, demonstrates a long-term survival of nearly 70% and develops a clinically applicable and readily measurable set of pretransplant factors that determine posttransplant outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724633      PMCID: PMC1514517          DOI: 10.1097/01.SLA.0000064365.54197.9E

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  43 in total

1.  Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure.

Authors:  B N Tandon; J Bernauau; J O'Grady; S D Gupta; R E Krisch; Y F Liaw; K Okuda; S K Acharya
Journal:  J Gastroenterol Hepatol       Date:  1999-05       Impact factor: 4.029

2.  A simple model to estimate survival after retransplantation of the liver.

Authors:  J F Markmann; J Gornbein; J S Markowitz; M F Levy; G B Klintmalm; H Yersiz; M Morrisey; K Drazan; D G Farmer; R M Ghobrial; J Goss; P Seu; P Martin; L I Goldstein; R W Busuttil
Journal:  Transplantation       Date:  1999-02-15       Impact factor: 4.939

Review 3.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

4.  A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Authors:  R M Ghobrial; R Steadman; J Gornbein; C Lassman; C D Holt; P Chen; D G Farmer; H Yersiz; N Danino; E Collisson; A Baquarizo; S S Han; S Saab; L I Goldstein; J A Donovan; K Esrason; R W Busuttil
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

Review 5.  Split liver transplantation.

Authors:  R W Busuttil; J A Goss
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

6.  Liver transplantation for fulminant hepatic failure in the pediatric patient.

Authors:  J A Goss; C R Shackleton; M Maggard; K Swenson; P Seu; S V McDiarmid; R W Busuttil
Journal:  Arch Surg       Date:  1998-08

7.  Fulminant hepatic failure: the role of liver transplantation as primary therapy.

Authors:  J J Brems; J R Hiatt; K P Ramming; W J Quinones-Baldrich; R W Busuttil
Journal:  Am J Surg       Date:  1987-07       Impact factor: 2.565

8.  Etiology and outcome for 295 patients with acute liver failure in the United States.

Authors:  F V Schiodt; E Atillasoy; A O Shakil; E R Schiff; C Caldwell; K V Kowdley; R Stribling; J S Crippin; S Flamm; K A Somberg; H Rosen; T M McCashland; J E Hay; W M Lee
Journal:  Liver Transpl Surg       Date:  1999-01

9.  Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria.

Authors:  A O Shakil; D Kramer; G V Mazariegos; J J Fung; J Rakela
Journal:  Liver Transpl       Date:  2000-03       Impact factor: 5.799

10.  Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis.

Authors:  R K Dhiman; A K Seth; S Jain; Y K Chawla; J B Dilawari
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

View more
  30 in total

1.  Intercontinental comparison of patient cohorts: what can we learn from it?

Authors:  P Schemmer; L Fischer; J Schmidt; M W Büchler
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

2.  Dynamic tracking of stem cells in an acute liver failure model.

Authors:  Tarek Ezzat; Dipok Kumar Dhar; Massimo Malago; Steven W M Olde Damink
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

3.  End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

Authors:  Joseph Ahn; Taft Bhuket; Sasan Mosadeghi; Catherine Frenette; Benny Liu; Robert J Wong
Journal:  Hepatol Int       Date:  2016-05-24       Impact factor: 6.047

Review 4.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

5.  Successful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxis.

Authors:  Tuğrul Çakır; Cengiz Ara; Hacı Vural Soyer; Suleyman Koc
Journal:  BMJ Case Rep       Date:  2015-06-23

Review 6.  [Long-term results after liver transplantation].

Authors:  H Schrem; N Till; T Becker; H Bektas; M P Manns; C P Strassburg; J Klempnauer
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

Review 7.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

8.  Aetiology and outcome of acute liver failure.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bridget Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

9.  Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience.

Authors:  Olivier Detry; Arnaud De Roover; Carla Coimbra; Jean Delwaide; Marie-France Hans; Marie-Hélène Delbouille; Joseé Monard; Jean Joris; Pierre Damas; Jacques Belaïche; Michel Meurisse; Pierre Honoré
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

10.  Live donor liver transplantation for acute liver failure: A single center experience.

Authors:  Siddharth Mehrotra; Naimish Mehta; Prashantha S Rao; Shailendra Lalwani; Vivek Mangla; Samiran Nundy
Journal:  Indian J Gastroenterol       Date:  2018-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.